PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness


Condition: Prostate Cancer

Study Type: Observational [Patient Registry]

Clinical Trials Identifier NCT 8-digits: NCT04995198

Sponsor: Prostate Cancer Clinical Trials Consortium

Phase:

Eligibility:

  • Age: minimum 18 Years maximum N/A
  • Gender: Male

Inclusion Criteria:

  • Have prostate cancer (any stage of disease or survivorship) diagnosed or documented through one of the following:
  • tissue biopsy, and/or
  • PSA greater than 100 ng/dL (1ng/ml), and/or
  • clear radiographic evidence of disease
  • Live in the United States (including Puerto Rico, Guam, American Samoa, US Virgin Islands, Northern Mariana Islands)

Exclusion Criteria:

  • Unable or unwilling to provide all of the necessary information for eligibility
  • Incomplete inclusion criteria

View trial on ClinicalTrials.gov